Antiepileptic drug treatment: outcomes and adherence (Q33999491)

30 July 2017

1 reference

title

Antiepileptic drug treatment: outcomes and adherence (English)

1 reference

30 July 2017

Garnett WR

1

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

20

1 reference

30 July 2017

issue

8 Pt 2

1 reference

30 July 2017

page(s)

191S-199S

1 reference

Descriptive epidemiology of epilepsy: contributions of population-based studies from Rochester, Minnesota

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Determinants of mortality in status epilepticus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Development of the quality of life in epilepsy inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Patient-validated content of epilepsy-specific quality-of-life measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Cost of epilepsy in the United States: a model based on incidence and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Cost of refractory epilepsy in adults in the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Payer costs of patients diagnosed with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Patients with refractory seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Commission on Outcome Measurement in Epilepsy, 1994-1997: final report

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Factors influencing compliance with antiepileptic drug regimes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

A comparison of rectal diazepam gel and placebo for acute repetitive seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Inhibition of epoxide hydrolase by valproic acid in epileptic patients receiving carbamazepine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Effect of Antacids on Phenytoin Bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Antiepileptic drugs. A review of clinically significant drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Neuropharmacology and drug interactions in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Adjunctive therapy in epilepsy: a cost-effectiveness comparison of two AEDs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Antiepileptic drugs as a cause of worsening seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Measurement of medication compliance in a clinical setting. Comparison of three methods in patients prescribed digoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

Outcomes Measurement: The Key to the Appropriate Use of Pharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.12.191S.35250

10.1592/PHCO.20.12.191S.35250

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference